image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates & Ideas

Dr Martens - D2C to drive margins higher

February 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • DOCS
  • Price:
  • 213p
Watches of Switzerland (a TMI idea at 295p in August ‘19, now 994p) is best known for its high end watches like Rolex, Patek Philippe and Audemars Piguet, the latter retailing for up to £55,000. You might ask what that has in common with shoe brand Dr Martens  (once the skinhead’s shoe of choice), whose iconic eight holed 1460 boot with the distinctive yellow welt stitch sells for £159; the answer is that both managements strive to ensure demand for their merchandise  exceeds supply while creating the perception of shortages. In Dr Martens’ case this feeling of exclusivity has given it sufficient “headroom” to raise prices to cover rising costs as confirmed by the +18% increase in sales (12% price, 6% volume growth) in the period ended 3 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Dr Martens - Iconic leather shoe brand sees £6 billion international sales opportunity (August 2022)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe

SUBSCRIBE NOW